Direct Evidence of Podocyte Damage in Cardiorenal Syndrome Type 2: Preliminary Evidence

Conclusions: CRS-2 may be associated with glomerular damage as evidenced by an elevated urinary podocin/Cr ratio. Modulators of RAAS may have a protective effect on urinary podocin loss.Cardiorenal Med 2015;5:125-134
Source: Cardiorenal Medicine - Category: Urology & Nephrology Source Type: research